2011-11824. Submission for OMB Review; Comment Request; Interactive Diet and Activity Tracking in AARP (iDATA): Biomarker Based Validation Study (NCI)
-
Start Preamble
SUMMARY:
Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Cancer Institute (NCI), the National Institutes of Health (NIH), has submitted to the Office of Management and Budget (OMB) a request to review and approve the information collection listed below. This proposed information collection was previously published in the Federal Register on March 14, 2011 (76 FR 13647) and allowed 60-days for public comment. There were no public comments in response to the notice. The purpose of this notice is to allow an additional 30 days for public comment. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has Start Printed Page 28053been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number.
Proposed Collection: Title: Interactive Diet and Activity Tracking in AARP (iDATA): Biomarker Based Validation Study. Type of Information Collection Request: New. Need and Use of Information Collection: The AARP-based study is one component of a multi-center biomarker validation study project involving two other large cohorts in the United States. The iDATA study involves large cohorts and provides the necessary sample size to evaluate the measurement error structure of the diet and physical activity assessment instruments and the heterogeneity of the measurement error structure across multiple and diverse study populations. The iDATA study will include 1,500 participants from the NIH-AARP Diet and Health Study and current AARP membership. The data collection instruments adhere to The Public Health Service Act, which provides authority to the Risk Factor Monitoring and Methods Branch in the Division of Cancer Control and Population Sciences and the Division of Cancer Epidemiology and Genetics. Both divisions work to reduce cancer in the U.S. population by establishing and supporting programs for the detection, diagnosis, prevention and treatment of cancer; and by collecting, identifying, analyzing and disseminating information on cancer research, diagnosis, prevention and treatment. Dietary and physical activity data will be gathered using the instruments as detailed below. In addition, biospecimen and clinic data will be also gathered. Frequency of Response: Monthly. Affected Public: Individuals. Type of Respondents: U.S. adults (persons aged 50-74). The annual reporting burden is provided for each study component as shown in the table below. There are no Capital Costs, Operating Costs, and/or Maintenance Costs to report.
Table 1—Estimates of Annual Burden Hours
Study component Instrument Number of respondents Frequency of response Average time per response (Minutes/Hour) Annual burden hours Type of Respondents for All Instruments: Adult Participants, 50-74 Years of Age Screening Pre-Screening Telephone Interview (Attachment 1) 1,334 1 15/60 (.25) 334 Clinic Eligibility Screening Interview (Attachment 3) 742 1 10/60 (.167) 124 Clinical Components NHANES III Anthropometry (Attachment 13) 742 3 10/60 (.167) 371 Resting Metabolic rate—Main (Attachment 7) 742 1 30/60 (.50) 371 Resting Metabolic Rate—Subsample (Attachment 7) 34 1 30/60 (.50) 17 Fasting Blood Protocol and Form (Attachment 5) 742 2 10/60 (.167) 247 Fitness test Protocol and Form (Attachment 10) 742 1 15/60 (.25) 186 Physical Activity Readiness Questionnaires—PAR-Q or PARmed-X (Attachments 11A-11B) 742 1 5/60 (.083) 62 Doubly Labelled Water—Main (Attachment 6) 742 1 40/60 (.667) 495 Doubly Labelled Water—Subsample (Attachment 6) 34 1 40/60 (.667) 23 Dietary Questionnaires Automated Self-Administered 24-hour Dietary Recall (ASA24) (Attachment 32) 742 6 30/60 (.50) 2,227 4-Day Food Record (Attachment 17) 742 2 60/60 (1.0) 1,485 Diet History Questionnaire (DHQ*Web-II) (Attachment 33) 742 2 45/60 (.75) 1,114 7-Day Food Checklist (Attachment 16) 742 2 60/60 (1.0) 1,485 Physical Activity Questionnaires Activities Completed over Time in 24 Hours (ACT24) (Attachment 34) 742 6 30/60 (.50) 2,227 Community Healthy Activities Model Program for Seniors (CHAMPS) (Attachment 19) 742 2 15/60 (.25) 371 Harvard Lifestyle Validation Study Physical Activity Questionnaire (Attachment 18) 742 2 10/60 (.167) 247 Sedentary Behaviors Questionnaire (Attachment 21) 742 2 20/60 (.33) 495 Stanford physical activity Survey (Attachment 22) 742 2 8/60 (.133) 198 NIH-AARP physical activity questions (Attachment 20) 742 2 10/60 (.167) 247 Home Collections 24 Hour Urine Collection Log (Attachment 14) 742 2 60/60 (1.0) 1,485 Start Printed Page 28054 Saliva Protocol and Form (Attachment 15) 742 3 10/60 (.167) 371 Heart Rate Monitor Log (Attachment 8) 34 1 35/60 (.583) 20 Physical Activity Monitor Log (Accelerometer/Inclinometer) (Attachment 12) 742 2 35/60 (.583) 866 Total 15,060 Request for Comments: Written comments and/or suggestions from the public and affected agencies should address one or more of the following points: (1) Evaluate whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Enhance the quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology.
Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the Attention: NIH Desk Officer, Office of Management and Budget, at OIRA_submission@omb.eop.gov or by fax to 202-395-6974. To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact Heather Bowles, Risk Factor Monitoring and Methods Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, 6130 Executive Blvd. MSC 7344, Bethesda, MD 20892-7335 or call non-toll-free number 301-496-7344 or e-mail your request, including your address to: bowleshr@mail.nih.gov.
Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication.
Start SignatureDated: May 9, 2011.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, National Institutes of Health.
[FR Doc. 2011-11824 Filed 5-12-11; 8:45 am]
BILLING CODE 4140-01-P
Document Information
- Comments Received:
- 0 Comments
- Published:
- 05/13/2011
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- 2011-11824
- Dates:
- Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication.
- Pages:
- 28052-28054 (3 pages)
- PDF File:
- 2011-11824.pdf
- Supporting Documents:
- » License Agreements; Start-Up Exclusive Evaluation Option: Activators of Human Pyruvate Kinase to Treat Cancer
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: National Institute of Nursing Research
- » Meetings: National Institute of Allergy and Infectious Diseases
- » Meetings: National Eye Institute
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: Center for Scientific Review
- » Meetings: Center for Scientific Review
- » Meetings: National Institute of Environmental Health Sciences
- » Meetings: National Human Genome Research Institute